Benlysta Injection, Powder, Lyophilized, For Solution
Product Images NDC 49401-102

Product Visual Gallery

This gallery contains 36 technical images submitted to the FDA as part of the official labeling for Benlysta (NDC 49401-102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glaxosmithkline Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Benlysta Spl Graphic 01)

A forest plot showing subgroup analysis of response rates comparing BENLYSTA (belimumab) to placebo across different induction regimens, biopsy classes, and baseline uPCR levels. The chart displays odds ratios with 95% confidence intervals, indicating whether BENLYSTA favors improved primary and complete renal response compared to placebo.*

FDA Label Image

Figure 2 (Benlysta Spl Graphic 02)

A line graph comparing the proportion of responders over time between patients treated with BENLYSTA (belimumab) plus standard therapy and those given placebo plus standard therapy. The x-axis represents time in weeks up to 104 weeks, and the y-axis shows percentage of responders with standard error bars for each group.*

FDA Label Image

Figure 3. Proportion (%) Of Sri-4 Responders (+/- Standard Error) By Visita (Benlysta Spl Graphic 03)

A line graph comparing the proportion of SRI-4 responders over 52 weeks between two groups: BENLYSTA plus standard therapy (n=554) and placebo plus standard therapy (n=279). The x-axis represents time in weeks, and the y-axis shows the percentage of responders. The BENLYSTA group demonstrates a higher response rate throughout the study period compared to placebo.*

FDA Label Image

Benlysta Prefilled Syringe Parts (Benlysta Spl Graphic 04)

An instructional diagram of a syringe with labeled parts including needle cap, needle, inspection window, body, finger grips, and plunger. The diagram highlights key components of the syringe structure for administration.*

FDA Label Image

Needle Guard (Benlysta Spl Graphic 05)

An instructional diagram showing a syringe with a needle guard activated. The needle guard is engaged over the needle, indicated by the label 'Needle Guard Activated,' demonstrating a safety mechanism to cover the needle after use.*

FDA Label Image

Benlysta Prefilled Syringe (Benlysta Spl Graphic 06)

An illustration of a medical injection device or syringe, showing detailed components including the plunger, barrel, and needle cover. The device is depicted in a side profile with various shades of gray, white, and purple.*

FDA Label Image

Gauze Pad Or Cotton Ball (Benlysta Spl Graphic 07)

FDA Label Image

Supplies_sharps_container_pfs (Benlysta Spl Graphic 08)

An illustration of a red sharps disposal container with a white lid that is partially open, used for safe disposal of needles and other sharp medical instruments.*

FDA Label Image

Figure_a_pfs (Benlysta Spl Graphic 09)

An instructional diagram showing a plastic tray containing a syringe and a vial labeled with an expiration date section marked 'Exp: Month - Year'. The image highlights the area of the vial label where the expiration date is printed, emphasizing the importance of noting this information before use.*

FDA Label Image

Figure_b_pfs (Benlysta Spl Graphic 10)

An instructional illustration showing a stopwatch indicating 30 minutes, with the text 'Wait 30 Minutes' prominently displayed on a yellow background. The image is labeled as Figure B, suggesting it is part of a step-by-step guide or instructions.*

FDA Label Image

Figure_c_pfs (Benlysta Spl Graphic 11)

An instructional drawing showing a hand holding a syringe containing BENLYSTA solution, labeled as Figure C. There is an arrow pointing to the solution inside the syringe, emphasizing the presence of the BENLYSTA injection preparation.*

FDA Label Image

Figure_d_pfs (Benlysta Spl Graphic 12)

An illustration showing possible injection sites for an intravenous drug administration. The highlighted areas for injection include the abdomen lower region and the outer upper thighs on a human figure. The image is labeled as Figure D.*

FDA Label Image

Figure_e_pfs (Benlysta Spl Graphic 13)

An illustration showing a hand holding a piece of gauze or cotton pad pressing on an injection site, likely depicting a step in post-injection care or preparation for intravenous administration.*

FDA Label Image

Figure_f_pfs (Benlysta Spl Graphic 14)

Illustration showing hands preparing a small vial with a syringe. One hand holds the vial while the other hand is removing a cap from the vial, indicated by an upward arrow. This figure demonstrates part of the process for preparing an injection, relevant to BENLYSTA (belimumab) lyophilized powder for intravenous injection.*

FDA Label Image

Figure_g_pfs (Benlysta Spl Graphic 15)

An instructional illustration labeled 'Figure G' showing a hand holding a syringe at a 45-degree angle while injecting into the skin of the opposite hand's finger, demonstrating proper injection technique for a drug product.*

FDA Label Image

Figure_h_pfs (Benlysta Spl Graphic 16)

An instructional illustration showing how to push the plunger all the way down on a syringe for intravenous injection. The two-panel diagram includes a close-up of fingers holding a syringe and inserting the plunger with an arrow indicating downward motion.*

FDA Label Image

Figure_i_pfs (Benlysta Spl Graphic 17)

An instructional illustration showing two steps to use a syringe. The first step depicts a hand pushing the thumb upward on the syringe plunger, and the second step shows the thumb moving back slowly to retract the plunger. The image guides proper handling technique.*

FDA Label Image

Figure_j_pfs (Benlysta Spl Graphic 18)

An instructional illustration labeled 'Figure J' showing a hand removing a cap from a syringe plunger before disposing of the syringe into a red sharps container.*

FDA Label Image

Autoinjector_parts_open-view_ai (Benlysta Spl Graphic 19)

An instructional diagram showing parts of a syringe or injection device, including labels for the Ring Cap, Gold Needle Guard, Inspection Window, Grey Stopper, and the location for the Expiration Date. The graphic visually explains these components but does not show product branding or dosage information.*

FDA Label Image

Benlysta Autoinjector (Benlysta Spl Graphic 20)

The image shows a BENLYSTA autoinjector device in a horizontal orientation. It is primarily light gray with a dark circular detail near the left end and a visible window-like feature near the center, suggesting where the injection status can be observed. The label below reads 'BENLYSTA autoinjector.' No dosage strength or manufacturer details are visible on the device.*

FDA Label Image

Gauze Pad Or Cotton Ball (Benlysta Spl Graphic 21)

An illustration showing a small container or vial next to a cotton ball or similar soft material. The image appears to depict an item associated with medical or pharmaceutical use, such as preparing or cleaning an injection site or handling a vial.*

FDA Label Image

Supplies_sharps_container_ai (Benlysta Spl Graphic 22)

Illustration of a red biohazard sharps container with an open white lid, typically used for disposal of medical needles and other sharp instruments in healthcare settings.*

FDA Label Image

Figure_a_ai (Benlysta Spl Graphic 23)

An illustration labeled Figure A showing a top-down view of a partially peeled back protective cover on a rectangular device, revealing an expiration date area labeled "Exp: Month - Year." The illustration highlights where the expiration date is printed on the device's surface, with an enlarged inset emphasizing the date location.*

FDA Label Image

Figure_b_ai (Benlysta Spl Graphic 24)

An instructional illustration featuring a stopwatch showing 30 minutes with a yellow highlight and the text 'Wait 30 Minutes' beside it, labeled as Figure B. The image likely indicates a waiting period instruction related to the product.*

FDA Label Image

Figure_c_ai (Benlysta Spl Graphic 25)

An instructional diagram showing how to visually inspect the BENLYSTA solution in a vial. The image highlights a hand holding the vial horizontally with an arrow pointing to the solution inside, accompanied by an eye symbol indicating visual inspection is required. The label 'BENLYSTA solution' is above the vial.*

FDA Label Image

Figure_d_ai (Benlysta Spl Graphic 26)

An anatomical illustration showing the front of a human torso and upper legs, highlighting injection sites. Purple shaded areas indicate recommended locations for intravenous injection administration, including the lower abdomen and the front upper thighs.*

FDA Label Image

Figure_e_ai (Benlysta Spl Graphic 27)

An instructional illustration showing a hand holding a cloth or wipe and cleaning a skin surface. The image is labeled 'Figure E.' It likely depicts a preparation step for an injection or medical procedure on the skin.*

FDA Label Image

Figure_f_ai (Benlysta Spl Graphic 28)

Illustration showing two hands holding parts of an injection device with arrows indicating the detachment and rotation of the components, as part of an instructional diagram for preparing an injection dose.*

FDA Label Image

Figure_g_ai (Benlysta Spl Graphic 29)

Instructional illustration for BENLYSTA (belimumab) intravenous injection showing a hand holding a syringe or injection device at a 90-degree angle to the skin, with the needle about to be inserted straight into the skin.*

FDA Label Image

Figure_h_ai (Benlysta Spl Graphic 30)

An instructional diagram showing a hand administering an injection vertically downward into the skin. A large black arrow points downward indicating the direction of the injection. This figure is labeled as Figure H.*

FDA Label Image

Figure_i_ai (Benlysta Spl Graphic 31)

An instructional diagram showing a hand holding a rectangular device with a purple indicator. The device emits a 'first click' sound, illustrated in a speech bubble, and is labeled as Figure I. The focus is on the purple indicator on the device.*

FDA Label Image

Figure_j_ai (Benlysta Spl Graphic 32)

Instructional illustration for use of an injection device showing a hand pressing the device to activate it, captioned with 'second click,' and an arrow pointing to a close-up of the device with a purple indicator. The text instructs to wait until the purple indicator stops moving, labeled as Figure J.*

FDA Label Image

Figure_k_ai (Benlysta Spl Graphic 33)

An instructional illustration labeled Figure K depicting hands disposing of a test strip and a small pack into a red biomedical waste container with an open lid. The image appears to be part of a medical or pharmaceutical guide.*

FDA Label Image

Benlysta 120 mg Per Vial Carton (Benlysta Spl Graphic 34)

Label for BENLYSTA (belimumab) injection, powder, lyophilized for solution, with a strength of 120 mg per vial. The label indicates the product is for intravenous infusion after dilution, single-dose vial, with reconstitution and dilution instructions provided. The labeler is GlaxoSmithKline LLC and includes a purple and white design with the GlaxoSmithKline (gsk) logo at the top right.*

FDA Label Image

Benlysta 400 mg Per Vial Carton (Benlysta Spl Graphic 35)

BENLYSTA (belimumab) 400 mg/vial injection, powder, lyophilized, for solution. The label includes instructions for reconstitution and dilution before intravenous infusion, specifying it as a single-dose vial. The labeler is GlaxoSmithKline LLC, and the packaging includes the NDC 49401-102-01 with the GSK logo.*

FDA Label Image

Benlysta 200 mg-ml 4 Count Carton (Benlysta Spl Graphic 36)

Benlysta (belimumab) Injection 200 mg/mL single-dose 1 mL prefilled autoinjectors package label for subcutaneous use. The label highlights once-weekly administration and includes contents such as injection autoinjectors, instructions, medication guide, and prescribing information. Labeled by GlaxoSmithKline LLC with NDC 49401-088-35.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.